Double-blind comparison of iodamide and diatrizoate for excretory urography

Yale J Biol Med. 1977 Nov-Dec;50(6):631-6.

Abstract

A double-blind comparison of meglumine iodamide and Renografin 60 (52% meglumine diatrizoate and 8% sodium diatrizoate) for bolus excretory urography was performed. Doses of 0.8 cc/kg. to a maximum of 55 cc were administered to fifty patients, twenty-five receiving each drug.There is a suggestion that iodamide may be superior to diatrizoate in pyelocalyceal opacification while being equal to diatrizoate in parenchymal opacification and in types and severity of side-effects.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Diatrizoate / analogs & derivatives*
  • Diatrizoate Meglumine* / adverse effects
  • Double-Blind Method
  • Female
  • Humans
  • Iodamide* / adverse effects
  • Iodobenzoates*
  • Male
  • Middle Aged
  • Time Factors
  • Urography*

Substances

  • Iodobenzoates
  • Diatrizoate
  • Diatrizoate Meglumine
  • Iodamide